Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · Real-Time Price · USD
2.520
-0.080 (-3.08%)
Apr 23, 2025, 4:00 PM EDT - Market closed
Telomir Pharmaceuticals Market Cap
Telomir Pharmaceuticals has a market cap or net worth of $75.60 million as of April 24, 2025. Its market cap has decreased by -61.95% in one year.
Market Cap
75.60M
Enterprise Value
74.42M
1-Year Change
-61.95%
Ranking
Category
Stock Price
$2.52
Market Cap Chart
Since the IPO on February 9, 2024, Telomir Pharmaceuticals's market cap has decreased from $207.27M to $75.60M, a decrease of -63.53%. That is a compound annual growth rate of -56.77%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 75.60M | -38.33% |
| Dec 31, 2024 | 122.58M | -40.86% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 741.24B |
| UnitedHealth Group | 396.32B |
| Johnson & Johnson | 374.72B |
| AbbVie | 311.73B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 225.08B |
| Novartis AG | 211.63B |
| AstraZeneca | 210.34B |